Skip to main content

D. E. Shaw & Co., Inc.

Position in DGX — Quest Diagnostics Inc

CIK 1009207 New York, NY

Position in DGX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$28,951,537
-$28,093,674 QoQ
Shares Held
147,727
-55.1% QoQ
Ownership
0.133%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in DGX Over Time

Shares Held

Position Value (USD)

Derivatives in DGX

reported options exposure · as of Sep 30, 2020
CallValue
$0
CallShares
0
PutValue
$469,409
PutShares
4,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

D. E. Shaw & Co., Inc. holds $1,676,976,764 across 27 Diagnostics & Research names. DGX ranks #12 (1.7% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in DGX

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $28,951,537 147,727
2025-12-31 $57,045,211 328,734
2024-12-31 $11,973,607 79,369
2024-09-30 $461,403 2,972
2024-06-30 $1,939,452 14,169
2024-03-31 $14,465,196 108,671
2023-12-31 $8,386,137 60,822
2023-09-30 $2,738,802 22,475
2023-06-30 $9,954,318 70,819
2023-03-31 $15,486,400 109,460
2022-12-31 $9,844,768 62,930
2022-09-30 $5,075,439 41,368
2022-06-30 $6,899,268 51,882
2022-03-31 $9,196,991 67,200
2021-12-31 $66,466,115 384,175
2021-09-30 $27,085,929 186,401
2021-06-30 $35,734,572 270,778
2021-03-31 $36,168,650 281,819
2020-12-31 $11,571,049 97,097
2020-09-30 $469,409 4,100
2020-06-30 $467,236 4,100
2020-03-31 $1,113,118 13,862